Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Antiviral Research|June 1, 2019
The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvantsYouri Lee, Eun-Ju Ko, Ki-Hye Kim, et al.
Vaccine|July 18, 2020
Adjuvant effects of killed Lactobacillus casei DK128 on enhancing T helper type 1 immune responses and the efficacy of influenza vaccination in normal and CD4-deficient miceYu-Jin Jung, Ki-Hye Kim, Eun-Ju Ko, et al.
Vaccine|May 19, 2019
Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient miceEun-Ju Ko, Youri Lee, Young-Tae Lee, et al.
Journal of Biomedical Nanotechnology|January 6, 2018
Cellular Immune Correlates Preventing Disease Against Respiratory Syncytial Virus by Vaccination with Virus-Like Nanoparticles Carrying Fusion ProteinsYoung-Tae Lee, Eun-Ju Ko, Ki-Hye Kim, et al.
Virology|July 22, 2015
Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infectionYoung-Tae Lee, Ki-Hye Kim, Hye Suk Hwang, et al.
Plos One|October 27, 2018
Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challengeSoojin Park, Youri Lee, Young-Man Kwon, et al.
Molecular Therapy. Methods & Clinical Development|June 27, 2022
Thermostable H1 hemagglutinin stem with M2e epitopes provides broad cross-protection against group1 and 2 influenza A virusesJeeva Subbbiah, Judy Oh, Ki-Hye Kim, et al.
Immune Network|July 9, 2019
Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle PlatformYoung-Man Kwon, Hye Suk Hwang, Young-Tae Lee, et al.
Nature Immunology|October 6, 2021
SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19Supriya Ravichandran, Juanjie Tang, Gabrielle Grubbs, et al.
Human Vaccines & Immunotherapeutics|January 28, 2017
Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton ratsHye Suk Hwang, Ki-Hye Kim, Youri Lee, et al.
Pageof 6